Product Description: VcMMAE-Deruxtecan is a Drug-Linker Conjugates for ADC, which is composed of a linker and a toxic molecule MMAE (HY-15162) (Microtubule inhibitor) and Exatecan (HY-13631) (DNA topoisomerase I inhibitor). VcMMAE-Deruxtecan can be used for ADC synthesis.
Applications: Cancer-programmed cell death
Formula: C121H159FN20O28
CAS Number: 2760408-75-9
Molecular Weight: 2360.67
Research Area: Cancer
Target: Drug-Linker Conjugates for ADC;Microtubule/Tubulin;Topoisomerase